0
0
53 words
0
Comments
Contract drug manufacturer Catalent Inc <a href="https://www.reuters.com/companies/CTLT.N" target="_blank">(CTLT.N)</a> on Friday warned that slow production at three of its facilities will impact its fiscal 2023 results and said CFO Thomas Castellano has ste…
You are the first to view
https://www.reuters.com/business/healthcare-pharmaceuticals/contract-drug-manufacturer-catalent-warns-hit-fourth-quarter-results-2023-04-14/
Create an account or login to join the discussion